Post by Sandoz

The future of healthcare affordability will be shaped by the choices we make in the next decade. ⏩    That was the clear message from our leadership team at the J.P. Morgan Healthcare Conference:  👉 Richard Saynor  👉 Remco Steenbergen  👉 Keren Haruvi Snir  👉 Craig Marks     They outlined how we are positioned to seize the unprecedented opportunity ahead.     The numbers tell the story: medicines worth around USD 660 billion will lose exclusivity over the next decade, and our pipeline of 400+ generics and 27 biosimilar medicines targets nearly two-thirds of this opportunity.    This is not just a commercial milestone. It is a major opportunity to shape the future of healthcare and improve outcomes for patients worldwide.     With strong partnerships, supportive policies, and a clear focus, we can turn loss of exclusivity into expanded access.    Listen to Richard Saynor's remarks to hear how we plan to lead this transformation (requires JPM login). 👇 https://lnkd.in/engfUSJe

Video Content